Man Group’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.7M Sell
184,177
-270,971
-60% -$9.85M 0.01% 792
2025
Q1
$16.5M Buy
455,148
+157,754
+53% +$5.71M 0.04% 445
2024
Q4
$12.5M Sell
297,394
-29,809
-9% -$1.25M 0.03% 550
2024
Q3
$18.2M Sell
327,203
-301,523
-48% -$16.7M 0.05% 443
2024
Q2
$25.8M Buy
628,726
+475,085
+309% +$19.5M 0.07% 344
2024
Q1
$7.17M Buy
153,641
+65,830
+75% +$3.07M 0.02% 798
2023
Q4
$4.2M Buy
+87,811
New +$4.2M 0.01% 951
2023
Q3
Sell
-42,277
Closed -$1.95M 1364
2023
Q2
$1.95M Buy
+42,277
New +$1.95M 0.01% 1189
2023
Q1
Sell
-38,211
Closed -$1.77M 1391
2022
Q4
$1.77M Buy
38,211
+3,773
+11% +$175K 0.01% 1149
2022
Q3
$1.43M Buy
+34,438
New +$1.43M 0.01% 1158
2022
Q2
Sell
-6,724
Closed -$488K 1202
2022
Q1
$488K Buy
+6,724
New +$488K ﹤0.01% 1567
2021
Q2
Sell
-16,645
Closed -$1.9M 1987
2021
Q1
$1.9M Sell
16,645
-28,503
-63% -$3.25M 0.01% 1125
2020
Q4
$6.25M Buy
45,148
+12,555
+39% +$1.74M 0.03% 674
2020
Q3
$2.68M Buy
32,593
+4,016
+14% +$330K 0.01% 1088
2020
Q2
$2.24M Sell
28,577
-8,771
-23% -$686K 0.01% 1021
2020
Q1
$1.66M Sell
37,348
-58,795
-61% -$2.61M 0.01% 957
2019
Q4
$4.11M Buy
96,143
+44,797
+87% +$1.91M 0.01% 1062
2019
Q3
$2.2M Sell
51,346
-16,217
-24% -$694K 0.01% 1206
2019
Q2
$4.29M Sell
67,563
-10,142
-13% -$644K 0.02% 1010
2019
Q1
$5.39M Buy
77,705
+34,662
+81% +$2.4M 0.02% 873
2018
Q4
$1.87M Sell
43,043
-6,341
-13% -$276K 0.01% 1238
2018
Q3
$3.77M Buy
+49,384
New +$3.77M 0.01% 1136